This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.
The drug FLIXONASE contains one active pharmaceutical ingredient (API):
1
|
UNII
O2GMZ0LF5W - FLUTICASONE PROPIONATE
|
|
Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| FLIXONASE Nasal spray | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| FLIXONASE Nasal drops | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R01AD08 | Fluticasone | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 510603001172315, 510603002179313 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 29604-1-01-11 |
| EE | Ravimiamet | 1007233, 1173620, 1643228, 1762950 |
| ES | Centro de información online de medicamentos de la AEMPS | 60483, 62771, R-2948IP |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 018285, 021100, 431809 |
| FR | Base de données publique des médicaments | 61748649 |
| GB | Medicines & Healthcare Products Regulatory Agency | 138764, 142336, 181549, 196125, 28109, 381341, 43807 |
| HK | Department of Health Drug Office | 47400 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-653844542 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1073034, 1084743 |
| MT | Medicines Authority | AA460/00801, MA192/04101, PI1438/03901A, PI908/02102A |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 441M95 |
| NG | Registered Drug Product Database | 04-2629 |
| NL | Z-Index G-Standaard | 14236664 |
| NL | Z-Index G-Standaard, PRK | 67202, 72346 |
| NZ | Medicines and Medical Devices Safety Authority | 5254 |
| PL | Rejestru Produktów Leczniczych | 100024517, 100193504 |
| SG | Health Sciences Authority | 07090P |
| TN | Direction de la Pharmacie et du Médicament | 8573021 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699522543014 |
| ZA | Health Products Regulatory Authority | 33/21.5.1/0329, X/21.5.1/359 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.